Author(s): Arora Neha | Singh Kamaljit | Bilandi Ajay | Garg Tarun
Journal: International Research Journal of Pharmacy
ISSN 2230-8407
Volume: 3;
Issue: 1;
Start page: 96;
Date: 2012;
VIEW PDF
DOWNLOAD PDF 
Original page
Keywords: Probiotic | Bifidobacteria | colonic transit disorders | intestinal infections.
ABSTRACT
Probiotic are defined as live organisms, which confer benefits to the host. Their efficiency was demonstrated for the treatment of gastrointestinal disorders, respiratory infections, and allergic symptoms, but their use is mostly limited to bacterial and viral diseases. During the last decade, probiotic as means for the control of parasite infections were reported covering mainly intestinal diseases but also some nongut infections that are all of human and veterinary importance. In most cases, evidence for a beneficial effect was obtained by studies using animal models. In a few cases, cellular interactions between probiotic and pathogens or relevant host cells were also investigated using in vitro culture systems. WHO have given special guidelines for probiotic. Bifidobacteria have been studied for their efficacy in the prevention and treatment of a broad spectrum of animal and/or human gastrointestinal disorders, such as colonic transit disorders, intestinal infections, and colonic adenomas and cancer.
Journal: International Research Journal of Pharmacy
ISSN 2230-8407
Volume: 3;
Issue: 1;
Start page: 96;
Date: 2012;
VIEW PDF
DOWNLOAD PDF Original pageKeywords: Probiotic | Bifidobacteria | colonic transit disorders | intestinal infections.
ABSTRACT
Probiotic are defined as live organisms, which confer benefits to the host. Their efficiency was demonstrated for the treatment of gastrointestinal disorders, respiratory infections, and allergic symptoms, but their use is mostly limited to bacterial and viral diseases. During the last decade, probiotic as means for the control of parasite infections were reported covering mainly intestinal diseases but also some nongut infections that are all of human and veterinary importance. In most cases, evidence for a beneficial effect was obtained by studies using animal models. In a few cases, cellular interactions between probiotic and pathogens or relevant host cells were also investigated using in vitro culture systems. WHO have given special guidelines for probiotic. Bifidobacteria have been studied for their efficacy in the prevention and treatment of a broad spectrum of animal and/or human gastrointestinal disorders, such as colonic transit disorders, intestinal infections, and colonic adenomas and cancer.
